Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
European patent offices raise fees
Europe
Two of Europe’s most important IP offices have implemented fee increases this month, with some long-standing UK charges, dating back to the late 1990s, finally seeing a rise.   2 April 2026
UPC refuses early knockout in Illumina–Element dispute
Europe
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal.   2 April 2026
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
Americas
After years of strict patent rules, Argentina is changing course. New IP reforms are putting the country back on the map, but how companies handle the transition will matter.   1 April 2026
Asia
The clash between one of India’s largest B2B marketplaces and the country’s drugs regulator challenges the “passive” position of such platforms with regards to allegedly unlawful pharmaceutical listings, says Aarti Aggarwal of Remfry & Sagar.   31 March 2026
Europe
Judges found no reason to set aside provisional measures issued by a local division, following a challenge from Sinocare and A Menarini Diagnostics.   30 March 2026
Americas
A long-running patent clash over gene editing returns to a fundamental question, as a US court takes another look at the evidence.   30 March 2026
Biotechnology
The Swiss pharma giant targets next-generation anti-IgE biologics as it looks to extend its dominance in the market.   27 March 2026
Europe
LSIPR sister title launches vetted list celebrating leading in-house counsel who demonstrate exceptional ability in managing their organisation's IP portfolio, legal team, and IP culture.   26 March 2026
Biotechnology
As the world moves past the pandemic, a massive legal struggle over the future of mRNA technology is just hitting its stride. LSIPR visualises the litigation defining the next era.   25 March 2026
Careers
Two senior hires from a rival firm bring litigation expertise across life sciences and tech disputes.   25 March 2026